Literature DB >> 23443876

[Paraneoplastic neurological syndromes].

O Stich1, S Rauer.   

Abstract

Paraneoplastic neurological syndromes (PNS) are very rare, remote effects of malignancies. Well-characterised antibodies against intracellular neuronal antigens are well-known in association with distinct tumors and with classical and non-classical syndromes. In this review article the current aspects of classification, pathophysiology, underlying tumors, antineuronal autoantibodies and diagnostic and therapeutic aspects of syndromes affecting the central nervous system are summarized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23443876     DOI: 10.1007/s00115-012-3603-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  13 in total

Review 1.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

2.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

3.  Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

Authors:  M J Titulaer; R Soffietti; J Dalmau; N E Gilhus; B Giometto; F Graus; W Grisold; J Honnorat; P A E Sillevis Smitt; R Tanasescu; C A Vedeler; R Voltz; J J G M Verschuuren
Journal:  Eur J Neurol       Date:  2010-09-29       Impact factor: 6.089

4.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

5.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

Authors:  M L Albert; J C Darnell; A Bender; L M Francisco; N Bhardwaj; R B Darnell
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

6.  Aquaporin-4 autoantibodies in a paraneoplastic context.

Authors:  Sean J Pittock; Vanda A Lennon
Journal:  Arch Neurol       Date:  2008-05

7.  Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.

Authors:  Sean J Pittock; Thomas J Kryzer; Vanda A Lennon
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

8.  Cerebrospinal fluid study in paraneoplastic syndromes.

Authors:  D Psimaras; A F Carpentier; C Rossi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-03-25       Impact factor: 10.154

9.  Neurological course of long-term surviving patients with SCLC and anti-Hu syndrome.

Authors:  A Poepel; S Jarius; L C Heukamp; H Urbach; C E Elger; C G Bien; R Voltz
Journal:  J Neurol Sci       Date:  2007-08-15       Impact factor: 3.181

Review 10.  Antibodies and neuronal autoimmune disorders of the CNS.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  J Neurol       Date:  2009-12-25       Impact factor: 4.849

View more
  2 in total

Review 1.  [Principles of autoimmune and paraneoplastic encephalitis].

Authors:  C G Bien
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

2.  Plasmapheresis Responsive Rapid Onset Dementia with Predominantly Frontal Dysfunction in the Context of Hashimoto's Encephalopathy.

Authors:  Dominique Endres; Magnus S Vry; Petra Dykierek; Anne N Riering; Eva Lüngen; Oliver Stich; Rick Dersch; Nils Venhoff; Daniel Erny; Irina Mader; Philipp T Meyer; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2017-10-26       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.